Bulletin of the World Health Organization

Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia

Otgon Bataar, Ganbold Lundeg, Ganbat Tsenddorj, Stefan Jochberger, Wilhelm Grander, Inipavudu Baelani, Iain Wilson, Tim Baker, Martin W Dünser & for the Helfen Berührt Study Team

Volume 88, Number 11, November 2010, 839-846

Table 2. Availability of drugs needed to implement Surviving Sepsis Campaign guidelines in 38 secondary and tertiary hospitals in Mongolia, 2009

Material Always
 Sometimes
 Never
 Don't know
No. % No. % No. % No. %
Oxygen 37 97.4 1 2.6 0 0 0 0
Antibiotic
Ampicillin 36 94.7 2 5.3 0 0 0 0
Gentamycin 36 94.7 1 2.6 1 2.6 0 0
3rd/4th generation cephalosporin 25 65.8 12 31.6 1 2.6 0 0
Piperacillin 0 0 3 7.9 24 63.2 11 28.9
Carbapenem 0 0 8 21.1 19 50 11 28.9
IV fluids
Crystalloids 35 92.1 3 7.9 0 0 0 0
Colloids 24 63.2 11 28.9 2 5.3 1 2.6
Blood products
Red blood cells 24 64.9 13 35.1 0 0 0 0
Fresh frozen plasma (n = 37) 21 56.8 10 27 6 16.2 0 0
Platelets (n = 37) 9 24.3 17 45.9 11 29.7 0 0
Cardiovascular drugs
Noradrenaline 1 2.6 9 23.7 27 71.1 1 2.6
Propofol 31 81.6 6 15.8 1 2.6 0 0
Succinylcholine 28 73.7 5 13.2 3 7.9 2 5.3
ND muscle relaxant 30 78.9 4 10.5 3 7.9 1 2.6
IV opiate/opioid 32 84.2 6 15.8 0 0 0 0
Diazepam 36 94.7 2 5.3 0 0 0 0
Midazolam 6 15.8 12 31.6 18 47.4 2 5.3
Other
Insulin 32 84.2 6 15.8 0 0 0 0
Heparin or LMW heparin 29 76.3 9 23.7 0 0 0 0
H2 blockers (n = 37) 30 81.1 5 13.5 2 5.4 0 0
Proton pump inhibitor 29 76.3 7 18.4 2 5.3 0 0
Activated protein C 0 0 0 0 33 86.8 5 13.2

H2, histamine receptor 2; IV, intravenous; LMW, low molecular weight; ND, non-depolarizing.